Literature DB >> 12777436

Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies.

Rebecca Troisi1, Nancy Potischman, James M Roberts, Roberta Ness, William Crombleholme, David Lykins, Pentti Siiteri, Robert N Hoover.   

Abstract

BACKGROUND: Epidemiological studies show a substantially reduced risk of breast cancer in adult daughters of preeclamptic pregnancies, and modest risk reductions have been demonstrated for mothers also. Alterations in pregnancy hormone concentrations, particularly lower in utero exposure to oestrogen, are hypothesized to mediate this association.
METHODS: Pregnancy hormone concentrations were measured in maternal sera collected at hospital admission for labour and delivery from 86 preeclamptic and 86 uncomplicated, singleton pregnancies matched on length of gestation, maternal age, parity, and type of delivery.
RESULTS: Case and control pregnancies were similar in several maternal and pregnancy factors. Serum unconjugated oestradiol, oestrone, and oestriol concentrations were not lower in preeclamptic pregnancies in a matched analysis with adjustment for race and whether blood was collected before or after labour commenced. Serum unconjugated androstenedione (506.3 versus 316.0 ng/dl; P = 0.0007) and testosterone concentrations (214.5 versus 141.9 ng/dl; P = 0.004), however, were significantly higher in preeclamptic compared with control pregnancies, whereas dehydroepiandrosterone (DHEA) and DHEA sulphate did not differ.
CONCLUSIONS: These data do not support the hypothesis that cancer risk in mothers and offspring of preeclamptic pregnancies is explained by exposure to lower maternal blood oestrogen concentrations, but raise the possibility that androgens play a role.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12777436     DOI: 10.1093/ije/dyg094

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  31 in total

1.  Pre-eclampsia and the risk of cancer.

Authors:  Aliki Taylor
Journal:  BMJ       Date:  2004-04-17

2.  Long-term stability of maternal prenatal steroid hormones from the National Collaborative Perinatal Project: still valid after all these years.

Authors:  Laura R Stroud; Catherine Solomon; Edmond Shenassa; George Papandonatos; Raymond Niaura; Lewis P Lipsitt; Kaja Lewinn; Stephen L Buka
Journal:  Psychoneuroendocrinology       Date:  2007-01-31       Impact factor: 4.905

3.  Associations of pregnancy characteristics with maternal and cord steroid hormones, angiogenic factors, and insulin-like growth factor axis.

Authors:  Jessica M Faupel-Badger; Yuping Wang; S Ananth Karumanchi; Frank Stanczyk; Michael Pollak; Thomas McElrath; Robert N Hoover; Rebecca Troisi
Journal:  Cancer Causes Control       Date:  2011-09-24       Impact factor: 2.506

4.  Elevated Testosterone Reduces Uterine Blood Flow, Spiral Artery Elongation, and Placental Oxygenation in Pregnant Rats.

Authors:  Kathirvel Gopalakrishnan; Jay S Mishra; Vijayakumar Chinnathambi; Kathleen L Vincent; Igor Patrikeev; Massoud Motamedi; George R Saade; Gary D Hankins; Kunju Sathishkumar
Journal:  Hypertension       Date:  2016-01-18       Impact factor: 10.190

Review 5.  A Narrative Review of Placental Contribution to Adverse Pregnancy Outcomes in Women With Polycystic Ovary Syndrome.

Authors:  Angela S Kelley; Yolanda R Smith; Vasantha Padmanabhan
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

Review 6.  Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature.

Authors:  Sarah Nechuta; Nigel Paneth; Ellen M Velie
Journal:  Cancer Causes Control       Date:  2010-03-12       Impact factor: 2.506

7.  Fetal sex-related dysregulation in testosterone production and their receptor expression in the human placenta with preeclampsia.

Authors:  K Sathishkumar; M Balakrishnan; V Chinnathambi; M Chauhan; G D V Hankins; C Yallampalli
Journal:  J Perinatol       Date:  2011-09-08       Impact factor: 2.521

Review 8.  Gestational Hyperandrogenism in Developmental Programming.

Authors:  Christopher Hakim; Vasantha Padmanabhan; Arpita K Vyas
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

9.  Cancer after pre-eclampsia: follow up of the Jerusalem perinatal study cohort.

Authors:  Ora Paltiel; Yehiel Friedlander; Efrat Tiram; Micha Barchana; Xiaonan Xue; Susan Harlap
Journal:  BMJ       Date:  2004-03-05

10.  Testosterone alters maternal vascular adaptations: role of the endothelial NO system.

Authors:  Vijayakumar Chinnathambi; Meena Balakrishnan; Jayanth Ramadoss; Chandrasekhar Yallampalli; Kunju Sathishkumar
Journal:  Hypertension       Date:  2013-01-21       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.